If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 485.00
Ask: 489.00
Change: 4.00 (0.83%)
Spread: 4.00 (0.825%)
Open: 481.00
High: 488.00
Low: 480.00
Prev. Close: 481.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Executive Officer

4 Mar 2024 07:00

RNS Number : 3428F
Treatt PLC
04 March 2024
 

4 March 2024

 

TREATT PLC

 ("Treatt" or "the Group")

 

Appointment of Chief Executive Officer

 

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces the appointment of David Shannon as Group Chief Executive Officer and a Director effective on 3 June 2024.

 

David joins Treatt from Croda International Plc where he has held a number of senior roles, recently as President of Consumer Care and an Executive Committee member. He has extensive experience in selling specialty ingredients in the B2B environment for the Flavour and Fragrance, Personal Care, Pharmaceutical and Agricultural industries worldwide.

 

David has a proven track record of sustainably growing businesses in dynamic markets. He has spent 13 years in various roles in the USA, a key market for Treatt, and has recently overseen a new manufacturing project in China. David's experience includes global business management, setting and delivering strategy, optimising science and innovation to drive revenue growth, identifying new ways to maximise revenue and attracting, retaining and developing employees. He has a degree in Chemistry from Edinburgh University.

 

Ryan Govender and Alison Sleight will continue as Interim CEO & Interim CFO respectively until David joins, when Ryan will resume as CFO and Alison as Group Finance & IT Director, and the Board thanks them for their continued commitment and strong contribution.

 

Vijay Thakrar, Chair of Treatt, commented:

 

"Following a robust search process that attracted a number of high quality candidates, we are thrilled that David is joining the Treatt team. He has highly relevant international experience delivering growth in an innovation led group, with a motivational and collaborative leadership style, which will enable him to lead Treatt through its next, exciting phase. The Board and I look forward to working closely with David, Ryan and our Leadership Team as they focus on realising the full potential of Treatt following the investments of recent years.

 

David Shannon added:

 

"I am honoured to be joining Treatt as CEO, a company that has a remarkable history of delivering excellence to its customers through sustainability, innovation and agility, supported by a unique culture. I am looking forward to working with everyone at Treatt to build on its strong foundation, unlock new opportunities and chart a path of sustained success."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13 in relation to the appointment.

 

 

 

Treatt plc +44 (0)1284 702500

Vijay Thakrar Chair

Ryan Govender ? Interim Chief Executive Officer

Alison Sleight Interim Chief Financial Officer

 

Brokers

Investec Bank plc +44 (0) 20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Mike Burke

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Eleni Menikou

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 350 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUPWUPCGMG
Date   Source Headline
29th Nov 20227:10 amRNSFull Year Results
10th Nov 20227:00 amRNSNotice of Results
9th Nov 20228:50 amRNSChange of Company Secretary and Director’s Duties
1st Nov 20224:26 pmRNSDirectorate Change - Replacement
1st Nov 202210:05 amRNSBoard Change
17th Oct 20222:36 pmRNSHoling(s) in Company
17th Oct 20222:36 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
16th Sep 20222:28 pmRNSBoard Committee Changes
1st Sep 202210:39 amRNSNotification of Transaction of a Director
31st Aug 20222:37 pmRNSNotification of Transactions of Director
16th Aug 202211:33 amRNSNotification of Transactions of Director
16th Aug 202211:30 amRNSNotification of Transactions of Director
15th Aug 202211:40 amRNSNotification of Transactions of Director
15th Aug 202211:37 amRNSNotification of Transactions of Director
15th Aug 20227:00 amRNSTrading Update
9th Aug 20223:25 pmRNSHolding(s) in Company
14th Jul 20226:23 pmRNSNotification of Transactions of Director
11th Jul 20227:00 amEQSTreatt (TET): New facility to drive growth
24th Jun 20221:15 pmRNSChairman Succession and Board Change
23rd Jun 202210:04 amRNSDirector Declaration
22nd Jun 20227:00 amRNSVoting Rights and Capital
21st Jun 20222:43 pmRNSHolding(s) in Company
20th Jun 20225:25 pmRNSNotification of Transactions of Director
20th Jun 20225:22 pmRNSNotification of Transactions of Director
8th Jun 20224:50 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st May 20222:54 pmRNSHolding(s) in Company
27th May 20227:00 amRNSCapital Markets Day
19th May 20225:03 pmRNSHolding(s) in Company
17th May 202211:50 amRNSHolding(s) in Company
13th May 20224:37 pmRNSHolding(s) in Company
13th May 20224:37 pmRNSNotification of Transactions of Director
12th May 20226:17 pmRNSHolding(s) in Company
12th May 20225:07 pmRNSHolding(s) in Company
12th May 202212:09 pmRNSNotification of Transactions of Director
11th May 20224:24 pmRNSHolding(s) in Company
11th May 20223:18 pmRNSNotification of Transactions of Director
10th May 20227:00 amRNSHalf-year Report
27th Apr 202210:28 amRNSDirector Declaration
11th Apr 20227:00 amRNSHalf Year Trading Update and Notice of Results
1st Apr 20221:59 pmRNSVoting Rights and Capital
30th Mar 20223:00 pmRNSNotification of Transactions of Director
24th Mar 20225:02 pmRNSNotification of Transactions of a PCA
22nd Mar 20224:55 pmRNSNotification of Transactions of Directors & PCA
22nd Mar 20229:10 amRNSDirector Declaration
8th Mar 202211:09 amRNSStandard Form for notification of major holdings
7th Mar 20222:19 pmRNSNotifications of Transactions of Director
7th Mar 202210:41 amRNSNotification of Transactions of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.